NIKKEI 225
40,074.69 +443.63 (+1.12%) HANG SENG
17,769.14 +50.53 (+0.29%) CRUDE OIL
83.02 +0.21 (+0.25%) GOLD FUTURES
2,339.20 +5.80 (+0.25%) DOW
39,331.85 +162.33 (+0.41%) Bitcoin GBP
48,877.75 -626.00 (-1.26%)
GRFS Nov 2024 12.000 call
| Previous close | 0.2500 |
| Open | N/A |
| Bid | 0.0000 |
| Ask | 1.3500 |
| Strike | 12.00 |
| Expiry date | 2024-11-15 |
| Day's range | 0.2500 - 0.2500 |
| Contract range | N/A |
| Volume | |
| Open interest | 1 |
- Reuters
Unit of Grifols shareholder Scranton reaches debt refinancing deal
Scranton Enterprises, an entity tied to the Grifols family, said on Tuesday it has reached an agreement with a private investor to refinance 377 million euros ($404.5 million) in debt of one of its units. Spanish drugmaker Grifols' market value has shed billions of euros since short-sheller Gotham City Research released a report in early January accusing the company of overstating earnings and understating debt. Grifols has repeatedly denied the claims.
GlobeNewswireGrifols’ Biotest to achieve USD 1 billion in US sales of Yimmugo® over next seven years
Biotest, a Grifols Group company, is expected to launch its recently FDA-approved intravenous immunoglobulin in the U.S. in first quarter 2025 Yimmugo will be distributed by Kedrion in the U.S. as part of a broader Group channel strategy, with Grifols focusing on continued growth of its current portfolio for this market It adds to Grifols’ strong franchise of intravenous and subcutaneous immunoglobulins to meet growing patient demand for these therapeutics Yimmugo will be followed by other prote
Simply Wall St.Grifols Leads Three Stocks That May Be Priced Below Their Estimated True Value
As global markets exhibit mixed signals with modest gains in the U.S. and challenges in sectors like Chinese real estate, investors are keenly watching for opportunities that might be undervalued. In this environment, identifying stocks such as Grifols that potentially trade below their intrinsic value could offer attractive entry points amidst current market conditions.
